Aspira Pathlab & Diagnostics Limited

BSE: ASPIRA540788ISIN INE500C01017

Healthcare
Healthcare Service Provider

BSE listing

Share price

₹115.00+5.47 (+4.99%)

as of 18 Sep 2026

52W high: ₹135.88
52W low: ₹49.00
Off 52W high: -15.37%
1M return: +22.73%
3M return: -5.74%
6M return: +108.71%
1Y return: +76.95%
20D avg volume: 1,213
50 DMA: ₹99.36
200 DMA: ₹82.74

Key ratios Consolidated

Market cap: ₹118.37 Cr
Current price: ₹115.00
52W high / low: ₹135.88 / ₹49.00
Face value: ₹10.00
P/E: 0.00
P/B: —
EPS (TTM): ₹0.00
Book value / share: —
ROE: —
ROCE: 15.70%
Operating margin: —
Net margin: —
Debt / equity: 0.10
Net debt: ₹-0.54 Cr
Interest cover: 6.77
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 35.2 days

Financials

Metric	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	5.25	5.78	—
	0.11	0.13	—
	4.89	5.18	—
	0.90	0.87	—
	0.00	0.00	—
	1.89	1.94	—
	0.09	0.09	—
	0.37	0.37	—
	1.64	1.91	—
	0.47	0.72	—
	0.00	-0.04	—
	0.47	0.68	—
	0.00	0.00	—
	0.42	0.68	—
	0.41	0.66	—
Key metrics
	0.93	1.14	—
	17.70%	19.70%	—
	8.00%	11.80%	—
	—	5.10%	—

Metric	FY25	FY24
Income statement
	22.00	—
	0.39	—
	20.32	—
	3.70	—
	0.00	—
	7.33	—
	0.35	—
	1.49	—
	7.45	—
	2.07	—
	-0.05	—
	2.02	—
	0.00	—
	2.02	—
	1.97	—
Key metrics
	3.86	—
	17.50%	—
	9.20%	—
	15.70%	—
	1.49	—
	0.91	—
	0.10	—
	-0.54	—
	35.2	—
Balance sheet
	17.46	—
	5.36	—
	1.75	—
	2.35	—
	0.51	—
	0.15	—
	3.86	—
	0.74	—
	2.37	—
	1.21	—
	0.00	—
	1.21	—
	12.17	—
Cash flow
	1.83	—
	0.12	—
	-0.99	—
	0.34	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q4 FY24
Income statement
	6.17	6.52	5.12	8.09	5.25	5.78	—
	0.12	0.14	0.13	0.14	0.11	0.13	—
	6.33	7.35	6.81	6.40	4.89	5.18	—
	0.88	1.22	1.12	1.28	0.90	0.87	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	2.49	2.29	2.45	2.15	1.89	1.94	—
	0.09	0.10	0.10	0.10	0.09	0.09	—
	0.41	0.40	0.38	0.40	0.37	0.37	—
	2.45	3.35	2.76	2.47	1.64	1.91	—
	-0.04	-0.69	-1.56	1.84	0.47	0.72	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.04	-0.69	-1.56	1.84	0.47	0.72	—
	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.04	-0.69	-1.56	1.84	0.47	0.72	—
	-0.04	-0.67	-1.52	1.78	0.46	0.70	—
Key metrics
	0.46	-0.19	-1.08	2.34	0.93	1.18	—
	7.50%	-2.90%	-21.10%	28.90%	17.70%	20.40%	—
	-0.60%	-10.60%	-30.50%	22.70%	9.00%	12.50%	—
	—	-3.80%	—	11.20%	—	5.40%	—
	17.50%	12.80%	—	—	—	—	—
	-108.50%	-195.80%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	25.90	24.98	22.00	—
	0.53	0.52	0.39	—
	26.89	25.45	20.32	—
	4.50	4.52	3.70	—
	0.00	0.00	0.00	—
	9.38	8.78	7.33	—
	0.39	0.39	0.35	—
	1.59	1.54	1.49	—
	11.03	10.22	7.45	—
	-0.45	0.05	2.07	—
	0.00	0.00	0.00	—
	-0.45	0.05	2.07	—
	0.00	0.00	0.00	—
	-0.45	0.05	2.07	—
	-0.45	0.05	2.01	—
Key metrics
	1.53	1.98	3.91	—
	5.91%	7.90%	17.80%	—
	-1.74%	0.20%	9.40%	—
	—	2.90%	16.00%	—
	—	13.50%	—	—
	—	-97.60%	—	—
	—	0.75	1.54	—
	—	29.00	0.91	—
	—	0.11	0.10	—
	—	0.09	-0.54	—
	—	18.8	35.2	—
Balance sheet
	—	18.51	17.51	—
	—	4.59	5.36	—
	—	1.26	1.75	—
	—	1.73	2.35	—
	—	0.70	0.51	—
	—	0.21	0.15	—
	—	3.88	3.86	—
	—	1.14	0.74	—
	—	3.11	2.37	—
	—	1.35	1.21	—
	—	0.00	0.00	—
	—	1.35	1.21	—
	—	12.23	12.22	—
Cash flow
	—	1.45	1.88	—
	—	-0.80	0.07	—
	—	-1.14	-0.99	—
	—	0.70	0.34	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Sales CAGR 10Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Profit CAGR 10Y: —
Sales YoY (TTM): —
Profit YoY (TTM): —

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Jun 2026

Promoter holding: 46.58%

Holder	Type	Holding	Previous	Change
ARVIND KARSANDAS BHANUSHALI	Promoter	13.79%	—	—
DEEPALI ARVIND BHANUSHALI	Promoter	9.43%	—	—
ADITYA AGRAWAL	Public	7.39%	—	—
JAY ARVIND BHANUSHALI	Promoter	7.23%	—	—
NIKUNJ VELJI MANGE	Promoter	7.11%	—	—
RAJ ARVIND BHANUSHALI	Promoter Group	6.97%	—	—
RAJESH PREMJI BHANUSHALI	Public	5.52%	—	—
PANKAJ JASHWANT SHAH	Public	4.86%	—	—
POOJA RAJESH BHANUSHALI	Public	3.60%	—	—
MANAS MODI	Public	3.36%	—	—
AMIT MODI	Public	2.92%	—	—
AMIT MODI HUF	Public	2.82%	—	—
PUSPAHAS AGRAWAL	Public	2.80%	—	—
RAM AWTAR RAMSISARIA	Public	2.40%	—	—
MANOJ RAMSISARIA	Public	1.99%	—	—

Public shareholders are disclosed individually only above 1%.

Filings & corporate actions

Recent announcements

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali16 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Enclosed herewith Constitution of Right Issue Committee for proposed right issue12 Sep 2026 · Company Update / General
Intimation under Regulation 30 (LODR) -Raising of Funds12 Sep 2026 · Company Update / Raising of Funds
The Board of Directors of the Company in its meeting held on 12th September, 2026 have considered and approved the following matters; 1) To raise Fund for an amount not exceeding Rs. 65,00,00,000/- ....12 Sep 2026 · Board Meeting / Outcome of Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali12 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/09/2026 ,inter alia, to consider and approve To consider approve ....7 Sep 2026 · Board Meeting / Board Meeting
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali5 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali3 Sep 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Pursuant to Regulation 36 (1)(b) of SEBI (LODR)2015, The Company has dispatched letter containing weblink of Annual Report for Financial year 2025-261 Sep 2026 · Company Update / General
Newspaper Publication Post Dispatch of 53rd AGM Notice & Annual Report for the Financial Year 2025-261 Sep 2026 · Company Update / Newspaper Publication
Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copy of the Notice of ....31 Aug 2026 · Others / Reg. 34 (1) Annual Report
Intimation of Notice of 53rd Annual General Meeting for the Financial Year 2025-2631 Aug 2026 · AGM/EGM / AGM
With reference to subject matter please find the attached Documents31 Aug 2026 · Corp. Action / Book Closure
Newspaper Advertisement - Information Regarding 53rd (Fifty -Three) Annual General Meeting of the company28 Aug 2026 · Company Update / Newspaper Publication
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali28 Aug 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Newspaper Publication for the Financial Result as on 30 June 202613 Aug 2026 · Company Update / Newspaper Publication
1. Board approved the appointment of Mr. Vaibhav Odhekar as Additional Executive Director with immediate Effect. 2. Board Approved the regularization of Mr. Vaibhav Odhekar as Executive ....12 Aug 2026 · Company Update / Change in Management
Unaudited Standalone Financial Results for quarter ended 30 June 202612 Aug 2026 · Result / Financial Results
Outcome of Board Meeting held on 12th August 202612 Aug 2026 · Board Meeting / Outcome of Board Meeting
Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Unaudited Financial ....6 Aug 2026 · Board Meeting / Board Meeting
Enclosed herewith Resignation of M/s Vishal J Bhanushali and Associated with effect from 13th August 20263 Aug 2026 · Company Update / General
Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director and Chief Executive Officer with effect from 03.08.20263 Aug 2026 · Company Update / Resignation of Chief Executive Officer (CEO)
Enclosed herewith Resignation of Mr. Pankaj Jashwant Shah from post of Managing Director cum Chief Executive Officer with effect from 03.08.20263 Aug 2026 · Company Update / Resignation of Managing Director
Enclosed herewith Resignation of Pankaj jashwant Shah (DIN:02836324)3 Aug 2026 · Company Update / Resignation of Director
Mr. Vaibhav Odhekar has resigned from Company as an Additional Executive Director with effect from close of business hours 25.07.202625 Jul 2026 · Company Update / Resignation of Director
Resignation of Mr. Vaibhav Odhekar as an Additional Executive Director from Company with effect from close of business hours on 25.07.202625 Jul 2026 · Company Update / Change in Directorate
Compliance Certificate in accordance with regulation 74(5) of SEBI (DP) regulation 2018 for quarter ended 30th June 202613 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of closure of Trading window for quarter ended 30.06.202624 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Intimation of Classification of Mr. Nikunj Mange and Mr. Jay Arvind Bhanushali as Promoters of the Company Pursuant to Completion of Open Offer11 Jun 2026 · Company Update / General
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shraddha Bhanushali & PACs11 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deepali Arvind Bhanushali & PACs11 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Raj Arvind Bhanushali & PACs11 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali & PACs10 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nikunj Mange & PACs10 Jun 2026 · Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Annual Secretarial Compliance Report for the year ended 31 March 2026 issued by Ms. Prajakta V. Padhye, Partner of Nilesh A. Pradhan & Co. LLP, Practising Company Secretaries, Mumbai25 May 2026 · Company Update / Reg.24(A)-Annual Secretarial Compliance
Newspaper Advertisement for the Financial Result as on 31 March 202625 May 2026 · Company Update / Newspaper Publication
The Board approved the appointment of Mr. Vaibhav Odhekar as an Additional Executive Director for 5 years23 May 2026 · Company Update / Change in Directorate
The disclosure regarding of Mrs. Neetu Maurya as a Company Secretary of the company with effect from 24.05.2026 was inadvertently filed under change in Control23 May 2026 · Company Update / Appointment of Company Secretary / Compliance Officer
Appointment of Mrs. Neetu Maurya as Company Secretary of the Company With Effect From 24.05.202623 May 2026 · Company Update / Change in Management Control
Appointment of M/s. Vishal J Bhanushali & Associates, as an Internal Auditor for F.Y. 2026-27 of the Company23 May 2026 · Company Update / General

Board meetings

12 Aug 2026 Board Meeting - Financial Results